Genetic variants associated with T2D risk factors such as glycemic variability or polymorphisms in angiotensin converting enzyme 2 (ACE2) have shown pleiotropic effects, including increased risk of CVD [29]. This evidence concerns the gene ACE2 and type 2 diabetes mellitus.